Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ardelyx Inc ARDX

Healthcare Biotechnology
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. It has two commercial products IBSRELA (tenapanor) and XPHOZAH. Its product pipeline includes RDX013 Program and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control... see more

Recent & Breaking News (NDAQ:ARDX)

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire August 2, 2021

ARDX INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Ardelyx, Inc.

PR Newswire August 2, 2021

ARDX NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit

PR Newswire August 2, 2021

EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important Deadline - ARDX

Business Wire August 2, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

Newsfile August 1, 2021

ARDELYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. and Encourages Investors to Contact the Firm

Business Wire July 30, 2021

ARDX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit

Business Wire July 30, 2021

INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Ardelyx Inc. (NASDAQ: ARDX)

Business Wire July 30, 2021

Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

PR Newswire July 29, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

PR Newswire July 28, 2021

REMINDER: Scott+Scott Attorneys at Law LLP Continues its Investigation into Ardelyx Inc. (ARDX)

Business Wire July 28, 2021

ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm

Business Wire July 21, 2021

Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc.

PR Newswire July 21, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

PR Newswire July 21, 2021

Scott+Scott Attorneys at Law LLP Announces Investigation into Ardelyx Inc. (ARDX)

Business Wire July 20, 2021

Investors Who Have Lost Money in Their Ardelyx, Inc. (ARDX) Investment Should Contact Block & Leviton, Who Is Investigating Potential Securities Fraud Claims Against Ardelyx

Newsfile July 20, 2021

(ARDX) Alert: Johnson Fistel, Investigates Ardelyx Following FDA Notification. Did You Lose Money on Your Ardelyx Investment?

PR Newswire July 20, 2021

SHAREHOLDER ALERT: Investigation of Ardelyx, Inc. Announced by Holzer & Holzer, LLC

Newsfile July 19, 2021

Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

PR Newswire July 19, 2021

Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021

PR Newswire June 7, 2021